HI TECH PHARMACAL CO INC 4

4 · HI TECH PHARMACAL CO INC · Filed Oct 10, 2013

Form 4

Period: 2013-10-08

DirectorCEO, President, Sec'y, Treas.10% Owner

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2013-10-09−75,000→ 0 total
Exercise: $14.99From: 2004-12-04Exp: 2013-12-04→ Common Stock (75,000 underlying)
Sale
Common Stock
2013-10-08$43.09/sh−23,000$991,070→ 1,290,703 total
Tax Payment
Common Stock
2013-10-09$43.09/sh−26,091$1,124,261→ 1,264,612 total
Exercise/Conversion
Common Stock
2013-10-09$14.99/sh+75,000$1,124,250→ 1,339,612 total

Holdings

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.06 to $43.12, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan
[F3]The option became exercisable in four (4) equal installments beginning on the first anniversary of the grant date.
[F4]Other than the option reflected on this form, Mr. Seltzer is also the holder of additional options to acquire an aggregate of 475,000 additional shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.

Documents

1 file